- Home
- STE vs EQR Comparison
STE vs EQR Comparison
Compare STE & EQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STE
- EQR
- Stock Information
- Founded
- STE 1985
- EQR 1993
- Country
- STE United States
- EQR United States
- Employees
- STE N/A
- EQR N/A
- Industry
- STE Industrial Specialties
- EQR Real Estate Investment Trusts
- Sector
- STE Health Care
- EQR Real Estate
- Exchange
- STE Nasdaq
- EQR Nasdaq
- Market Cap
- STE 23.0B
- EQR 24.7B
- IPO Year
- STE 1992
- EQR 1993
- Fundamental
- Price
- STE $248.80
- EQR $64.61
- Analyst Decision
- STE Buy
- EQR Buy
- Analyst Count
- STE 9
- EQR 12
- Target Price
- STE $268.25
- EQR $76.13
- AVG Volume (30 Days)
- STE 511.8K
- EQR 1.8M
- Earning Date
- STE 11-05-2025
- EQR 10-29-2025
- Dividend Yield
- STE 0.91%
- EQR 4.28%
- EPS Growth
- STE 61.94
- EQR 5.58
- EPS
- STE 6.53
- EQR 2.65
- Revenue
- STE $5,571,115,000.00
- EQR $3,044,764,000.00
- Revenue This Year
- STE $9.24
- EQR $4.90
- Revenue Next Year
- STE $6.05
- EQR $4.00
- P/E Ratio
- STE $38.37
- EQR $24.39
- Revenue Growth
- STE 6.42
- EQR 4.40
- 52 Week Low
- STE $200.98
- EQR $59.41
- 52 Week High
- STE $253.00
- EQR $78.37
- Technical
- Relative Strength Index (RSI)
- STE 56.34
- EQR 45.88
- Support Level
- STE $246.96
- EQR $65.56
- Resistance Level
- STE $253.00
- EQR $67.11
- Average True Range (ATR)
- STE 4.37
- EQR 1.14
- MACD
- STE -0.25
- EQR -0.06
- Stochastic Oscillator
- STE 69.12
- EQR 28.49
About STE STERIS plc (Ireland)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
About EQR Equity Residential of Beneficial Interest
Equity Residential owns a portfolio of 312 apartment communities with over 84,000 units and is developing two additional properties with 655 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.